Skip to content

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Inflammatory Profiles of Children at High Risk for Atherosclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00115232
Enrollment
300
Registered
2005-06-22
Start date
2004-07-31
Completion date
2007-03-31
Last updated
2008-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Hypercholesterolemia, Inflammation, Metabolic Syndrome X

Keywords

cardiovascular disease, metabolic syndrome, hypercholesterolemia, child, family history, inflammation

Brief summary

The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (cases), and healthy children without such a family history (controls). The design is a cross-sectional study, gathering a fasting blood sample and clinical and behavioral data on children and a parent.

Detailed description

Family history is a well known risk factor for early atherosclerosis. Whether inflammation plays a role in the increased risk of family history is not known. In this prospective single-center study, we are recruiting children with and without a family history of premature atherosclerotic disease, defined as occurring \< 55 years in males and \<65 years in females. Children are recruited primarily from a pediatric preventive cardiology clinic at Children's Hospital Boston. We measure anthropomorphic characteristics, fasting lipid profiles and inflammatory marker levels, including high sensitivity C-reactive protein (hsCRP), intracellular adhesion molecule 1 (ICAM-1), P-selectin, and tumor necrosis factor alpha receptor 2 (TNFαR2). In this sample of high-risk overweight children, Lp(a) and inflammatory markers could reflect cardiovascular risk outside lipid profiles.

Interventions

None listed

Sponsors

Sandra A. Daugherty Foundation
CollaboratorOTHER
Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 8-21 years * Parent able to participate * Fasting state * Live locally

Exclusion criteria

* Taking medication that may alter cholesterol levels or inflammatory state * Past or present inflammatory illnesses

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026